Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in genotype 2 hepatitis C relapsers
NCT01466192Phase 3Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- May 2012
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Mitsubishi Tanabe Pharma. Started May 2012; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01466192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01466192.